NCT04332978View on ClinicalTrials.gov

Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPerene

PHASE3CompletedINTERVENTIONAL
Enrollment

566

Participants

Timeline

Start Date

July 4, 2014

Primary Completion Date

April 1, 2020

Study Completion Date

April 1, 2020

Conditions
Perennial Allergic Rhinitis
Interventions
DRUG

Fluticasone Propionate

All Listed Sponsors
lead

Libbs Farmacêutica LTDA

INDUSTRY

NCT04332978 - Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPerene | Biotech Hunter | Biotech Hunter